TY - JOUR
T1 - Dual function of TGFβ in lens epithelial cell fate
T2 - Implications for secondary cataract
AU - Boswell, Bruce A.
AU - Korol, Anna
AU - West-Mays, Judith A.
AU - Musil, Linda S.
N1 - Funding Information:
L.M. and B.B. were supported by National Institutes of Health Grants R01EY022113 (National Eye Institute) and TR000128 (Oregon Clinical and Translational Research Institute, from the National Center for Advancing Translational Sciences and National Institutes of Health Roadmap for Medical Research). A.K. and J.W.-M. were supported by National Institutes of Health Grant EY017146.
Publisher Copyright:
© 2017 Obino, Diaz, et al.
PY - 2017/4/1
Y1 - 2017/4/1
N2 - The most common vision-disrupting complication of cataract surgery is posterior capsule opacifcation (PCO; secondary cataract). PCO is caused by residual lens cells undergoing one of two very different cell fates: either transdifferentiating into myofbroblasts or maturing into lens fber cells. Although TGFβ has been strongly implicated in lens cell fbrosis, the factors responsible for the latter process have not been identifed. We show here for the frst time that TGFβ can induce purifed primary lens epithelial cells within the same culture to undergo differentiation into either lens fber cells or myofbroblasts. Marker analysis confrmed that the two cell phenotypes were mutually exclusive. Blocking the p38 kinase pathway, either with direct inhibitors of the p38 MAP kinase or a small-molecule therapeutic that also inhibits the activation of p38, prevented TGFβ from inducing epithelial-myofbroblast transition and cell migration but did not prevent fber cell differentiation. Rapamycin had the converse effect, linking MTOR signaling to induction of fber cell differentiation by TGFβ. In addition to providing novel potential therapeutic strategies for PCO, our fndings extend the so-called TGFβ paradox, in which TGFβ can induce two disparate cell fates, to a new epithelial disease state.
AB - The most common vision-disrupting complication of cataract surgery is posterior capsule opacifcation (PCO; secondary cataract). PCO is caused by residual lens cells undergoing one of two very different cell fates: either transdifferentiating into myofbroblasts or maturing into lens fber cells. Although TGFβ has been strongly implicated in lens cell fbrosis, the factors responsible for the latter process have not been identifed. We show here for the frst time that TGFβ can induce purifed primary lens epithelial cells within the same culture to undergo differentiation into either lens fber cells or myofbroblasts. Marker analysis confrmed that the two cell phenotypes were mutually exclusive. Blocking the p38 kinase pathway, either with direct inhibitors of the p38 MAP kinase or a small-molecule therapeutic that also inhibits the activation of p38, prevented TGFβ from inducing epithelial-myofbroblast transition and cell migration but did not prevent fber cell differentiation. Rapamycin had the converse effect, linking MTOR signaling to induction of fber cell differentiation by TGFβ. In addition to providing novel potential therapeutic strategies for PCO, our fndings extend the so-called TGFβ paradox, in which TGFβ can induce two disparate cell fates, to a new epithelial disease state.
UR - http://www.scopus.com/inward/record.url?scp=85016791640&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016791640&partnerID=8YFLogxK
U2 - 10.1091/mbc.E16-12-0865
DO - 10.1091/mbc.E16-12-0865
M3 - Article
C2 - 28209733
AN - SCOPUS:85016791640
SN - 1059-1524
VL - 28
SP - 907
EP - 921
JO - Molecular biology of the cell
JF - Molecular biology of the cell
IS - 7
ER -